Investigational Site Number : 3760003

Ramat Gan 5262100

2 studies enrolling now · 5 studies all time

What they study most

Cancer, Chronic Graft Versus Host Disease, Multiple Sclerosis, Neoplasm, Plasma Cell Myeloma Refractory

Studies at this site

• Isatuximab in Combination With Novel Agents in RRMM - Master Protocol — Recruiting now
• A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK) — Recruiting now
• Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis — Running, not enrolling
• A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. — Running, not enrolling
• Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors — Stopped early